PHIRE_EU

Join us on Wednesday 15th October from 2 to 3 pm!

💡Bringing a #medicaldevice to market is never a straightforward journey. It’s a complex, collaborative process that calls for long-term commitment and a wide range of expertise. The #exploitation strategy is key. As one of the
@metagroup.bsky.social’s experts explains➡️https://www.phire-project.eu/

Our team was in Utrecht for the #IEEE_IUS2025!
It was an opportunity to share insights with the global scientific community. We were particularly happy to present our "Development and characterisation of a multi-scale #photoacoustic platform for next generation imaging applications."
#MedicalImaging

PHIRE discovered a new biomarker of aggressive tumours. A new scientific study led by the PHIRE scientists has identified a new molecular biomarker that could help doctors detect aggressive early-stage bladder cancer, such as high-grade non-muscle invasive...

Join our newsletter on LinkedIn! A new release was published this morning:
☑️2 new scientific publications
☑️5 new audio interviews
☑️1 join webinar in October

👉 www.linkedin.com/pulse/phire-...
#earlydetection #oncology

🔎 New paper!
We have recently published in the Frontiers in oncology journal a paper titled “High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1“ ➡️ www.phire-project.eu/resources/sc...
#Oncology #EU4Science #Urology #bladdercancer

Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”!
@phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social will discuss about how AI is transforming #oncology.

🔗 Register: events.teams.microsoft.com/event/1fba7a...

Gender Dimension - Phire Project The gender dimension in PHIRE Gender equality is a core value of the European Union and a strategic priority in Horizon Europe. The EU recognises that integrating […]

🧬Bladder cancer is 4 times more common in men, but women are often diagnosed later and face worse outcomes. Our approach ensures that our solution is not influenced by sex or biological differences, providing equitable care for all.👉 www.phire-project.eu/gender-dimen...
#GenderEquality#BladderCancer

We’re excited to see
@eurobioimaging.bsky.social spotlighting the PHIRE project! ☺️
Read the full story here 👉 www.eurobioimaging.eu/news/phire-a...
#HorizonEurope #CancerResearch #nanotech #photoacoustic #EUfunded #bladdercancer #precisionmedicine #ultrasoundimaging

We’re excited to share that PHIRE has joined the Deep Sync Health Community of Practice! 🧠🧪

It brings together innovative projects funded by the EIC, with a special focus on:

🔵 Neurotech
🔵 Medical imaging & AI
🔵 Women’s health

Discover more ➡️ deepsync.eu/project/phire/

#OpenScience

🚨🚨🚨

Please RT!

We're looking for a postdoc to join an exciting joint project between our lab @upf.edu & @crg.eu (Barcelona) and the Sander lab @mdc-berlin.bsky.social (Berlin) investigating how alternative splicing and microexons influences the maturation of pancreatic islets.

Deadline: 30/09/25👇

Horizon Europe 2028 - 2034: twice bigger, simpler, faster and more impactful Research and innovation news alert: As part of the next long-term EU budget 2028-2034, the Commission is proposing to double the budget of the research and innovation framework programme to €175 billi...

🔬 PHIRE is proud to be part of this ecosystem that pushes the boundaries of science and innovation. We look forward to seeing how the new programme will continue to support disruptive solutions like ours!

Read more ➡️ shorturl.at/HRWkT

📢 Big news from the European Commission!

Yesterday, President Ursula von der Leyen announced the next long-term EU’s budget. Running from 2028 to 2034, the new Horizon Europe aims to boost Europe’s competitiveness and fund solutions to real-world challenges.

🌊 We are in Southampton, UK!

Our partners gathered for a new meeting filed with insightful discussions and exchanges. 🚀

Thanks everybody for coming and Ascend Technologies for hosting us! 😊

Stay tuned for more updates!

#EUproject #MedicalResearch #EU4Science

💡 In PHIRE, we work alongside surgeons and urologists to make sure our technology meet their actual needs and it’s set up to make an impact in patients' outcomes. 🏥

🗣️ Listen to this interview with Marco Moschini, urologist at Ospedale San Raffaele, to learn more our project.

#EUproject

🩺 PHIRE has been featured at the 19th National UrOP Congress, a key event for Italy’s urology community! 👨‍⚕️👩‍⚕️

Our project coordinator, Massimo Alfano, delivered a lecture on the use of nanoparticles in the endoscopic diagnosis of bladder lesions. 🔬

👉 Learn more: www.phire-project.eu/objectives/

Have a look at the scientific paper that we published on @pnas.org!👀

It highlights the potential of our GNR-assisted theranostic strategy as a complementary solution to reduce the risk of nonvisible residual bladder cancer after current treatment.

Read it here➡️ www.phire-project.eu/resources/sc...

🔬 With PHIRE, we’re doing our part by developing a new solution to find and treat cancer lesions smaller than 1 mm, starting with bladder cancer.

Thanks to EU’s support, our work brings together innovative imaging, nanotechnology, and AI-powered techniques to make sure no lesion goes unnoticed. ✨

On #EuropeDay, we celebrate the Union that puts people’s health at the heart of its priorities. 💪

The EU Mission on Cancer is working to improve the lives of millions by advancing early detection, better diagnosis, and personalised care.

Learn more about the EU Cancer Mission➡️ shorturl.at/sk1ma

🔎 At PHIRE, we are committed to bringing innovative solutions to the clinic. Our nanoparticle-based technology aims to revolutionise the detection of small bladder cancer lesions, improving patient outcomes.

Learn more ➡️ www.phire-project.eu

#HorizonEurope #BladderCancer

✍️ Check out our latest article!

By combining optical and ultrasound technologies, photoacoustic imaging allows for clearer, deeper imaging, and with AI-assisted innovations, it can detect lesions as small as 1 mm.

Discover how PHIRE is advancing this technology 👉 shorturl.at/HZV3X

#EUresearch

😊 PHIRE was well represented at the #EMIM25!

Recently, our team had the opportunity to present the project at the European Molecular Imagine Meeting 2025.

It was a great opportunity to share our progress and connect with the scientific community! 🥼

#HorizonEurope #Photoacoustic #UltrasoundImaging

Are you already part of PHIRE’s community in Zenodo? 🤔

We like this platform due its commitment to open science, which is crucial for EU funded projects. Zenodo is an open source digital repository where we can share our work.

Follow us! ➡️https://zenodo.org/communities/phire/

#EUScience

🗎 New paper published!

Our team has published in Advanced Healthcare Materials an article about “Urine-stable aptamer-conjugated gold nanorods for the early detection of high-grade bladder cancer residual disease“.

Download it here 👉 www.phire-project.eu/resources/sc...

#EUScience #EICTransition

🗝️ Gold nanorods are key in PHIRE!

“These small particles with a nanometric size of gold can interact with light, allowing to use them in cancer detection and treatment through laser irradiation.” - explains Erica Locatelli, associate professor at the University of Bologna

🎧More ➡️ shorturl.at/JWPcT

YouTube video by PHIRE - eu project Phire Project - Official Video

👀 Have you seen PHIRE's official video yet?

🔎 We've created this video to showcase how PHIRE aims to revolutionise the way we approach chemoresistant neoplastic bladder cancer lesions smaller than 1 mm.

👉 youtu.be/MtG7fvm0P3k?...

#EUproject #EUCancerMission

PHIRE’s innovative approach overcomes limitations of current imaging techniques, surgery, and chemoresistance!🧪🔬

📖 Read more here: www.eventclass.it/emim2024/sci...

#EUCancerMission #EUproject #EUresearch

🔑 Key findings:
➡️ A specific marker was identified in 75% of clinical specimens of bladder CIS.
➡️ Targeted GNRs were stable in the urinary environment and achieved precise lesion detection and eradication.
➡️ A single treatment eradicated 90% of small lesions and doubled survival time.

#EUscience

🌟 PHIRE's researchers presented their study on “Image-guided photothermal therapy for bladder cancer lesions expressing marker of bladder CIS“, introducing an innovative image-guided photothermal therapy that combines imaging and thermal ablation to detect and treat bladder cancer lesions (<1mm).

A quick reminder to subscribe to PHIRE's newsletter for the latest updates on bladder cancer research and diagnostic imaging. 💙
Subscribe to receive PHIRE’s developments, insights on cancer research, health policies, events and more!
➡️ www.phire-project.eu#newsletter
#CancerResearch

🔎 The PHIRE team is developing a solution that enables the detection and physical treatment (theranostic) of bladder cancer smaller than 1 mm.

The adoption of the PHIRE solution will reduce social costs and improve the quality of life of patients. 💖💪

➡️ www.phire-project.eu

#Oncology #EUresearch